The FASEB Journal, Vol 2, 3022-3026, Copyright © 1988 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Cannabinoids and pain responses: a possible role for prostaglandins

SH Burstein, K Hull, SA Hunter and V Latham
Department of Biochemistry, University of Massachusetts Medical School, Worcester 01655.

The principal metabolite of delta 1-THC, delta 1-THC-7-oic acid exhibits significant analgesic action in the mouse hot plate test. The parent delta 1-THC has a similar effect when measured at later time points; however, 10 min after drug administration, a pronounced hyperalgesia is seen. This hyperalgesia can be inhibited by prior administration of either indomethacin or delta 1-THC-7-oic acid, presumably because of their ability to inhibit eicosanoid synthesis. Administration of prostaglandin E2 (PGE2), at doses that were a small fraction of the delta 1-THC given, resulted in a strong hyperalgesic response. Unlike delta 1-THC, the metabolite does not produce a cataleptic state in the mouse, which eliminates this as a basis for the hot plate response. The evidence presented is consistent with a mechanism in which the metabolite inhibits eicosanoid synthesis whereas the parent drug elevates tissue levels of prostaglandins.

This article has been cited by other articles:

				J. Zhang and C. Chen Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation J. Biol. Chem., August 15, 2008; 283(33): 22601 - 22611. [Abstract] [Full Text] [PDF]

				R. E. Vann, C. D. Cook, B. R. Martin, and J. L. Wiley Cannabimimetic Properties of Ajulemic Acid J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 678 - 686. [Abstract] [Full Text] [PDF]

				B. Kraft and H. G. Kress Indirect CB2 Receptor and Mediator-Dependent Stimulation of Human Whole-Blood Neutrophils by Exogenous and Endogenous Cannabinoids J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 641 - 647. [Abstract] [Full Text] [PDF]